249 related articles for article (PubMed ID: 26107941)
1. Chick Chorioallantoic Membrane Assay: A 3D Animal Model for Study of Human Nasopharyngeal Carcinoma.
Xiao X; Zhou X; Ming H; Zhang J; Huang G; Zhang Z; Li P
PLoS One; 2015; 10(6):e0130935. PubMed ID: 26107941
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
[TBL] [Abstract][Full Text] [Related]
3. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
[TBL] [Abstract][Full Text] [Related]
4. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma.
Chao TY; Chow KC; Chang JY; Wang CC; Tsao TY; Harn HJ; Chi KH
Cancer; 1996 Jul; 78(1):24-9. PubMed ID: 8646721
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma.
Tsai ST; Jin YT; Mann RB; Ambinder RF
Cancer; 1998 Apr; 82(8):1449-53. PubMed ID: 9554519
[TBL] [Abstract][Full Text] [Related]
6. Nasopharyngeal carcinoma: Epstein-Barr Virus significance.
Kottaridis SD; Panotopoulou E; Diamantis I; Goula I; Danilidis J; Fountzilas G
Anticancer Res; 1996; 16(2):785-9. PubMed ID: 8687129
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis.
Ming H; Lan Y; He F; Xiao X; Zhou X; Zhang Z; Li P; Huang G
Chin J Cancer; 2015 Aug; 34(10):459-67. PubMed ID: 26275421
[TBL] [Abstract][Full Text] [Related]
8. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma.
Horikawa T; Yang J; Kondo S; Yoshizaki T; Joab I; Furukawa M; Pagano JS
Cancer Res; 2007 Mar; 67(5):1970-8. PubMed ID: 17332324
[TBL] [Abstract][Full Text] [Related]
9. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
[TBL] [Abstract][Full Text] [Related]
10. The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma.
Chang KP; Hao SP; Lin SY; Ueng SH; Pai PC; Tseng CK; Hsueh C; Hsieh MS; Yu JS; Tsang NM
Laryngoscope; 2006 Apr; 116(4):541-6. PubMed ID: 16585856
[TBL] [Abstract][Full Text] [Related]
11. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia.
Pathmanathan R; Prasad U; Chandrika G; Sadler R; Flynn K; Raab-Traub N
Am J Pathol; 1995 Jun; 146(6):1355-67. PubMed ID: 7778675
[TBL] [Abstract][Full Text] [Related]
12. Expression of protease-activated receptor-2 (PAR-2) in patients with nasopharyngeal carcinoma: correlation with clinicopathological features and prognosis.
Li Z; Bian LJ; Li Y; Liang YJ; Liang HZ
Pathol Res Pract; 2009; 205(8):542-50. PubMed ID: 19269113
[TBL] [Abstract][Full Text] [Related]
13. The chick embryo chorioallantoic membrane as a model for tumor biology.
Ribatti D
Exp Cell Res; 2014 Nov; 328(2):314-24. PubMed ID: 24972385
[TBL] [Abstract][Full Text] [Related]
14. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis.
Chen CL; Ou DL
Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936
[TBL] [Abstract][Full Text] [Related]
15. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
[TBL] [Abstract][Full Text] [Related]
16. Effects of cyclooxygenase 2 inhibitors on biological traits of nasopharyngeal carcinoma cells.
Chen PY; Long QC
Acta Pharmacol Sin; 2004 Jul; 25(7):943-9. PubMed ID: 15210070
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma.
Mutirangura A; Pornthanakasem W; Theamboonlers A; Sriuranpong V; Lertsanguansinchi P; Yenrudi S; Voravud N; Supiyaphun P; Poovorawan Y
Clin Cancer Res; 1998 Mar; 4(3):665-9. PubMed ID: 9533535
[TBL] [Abstract][Full Text] [Related]
18. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
Ho CH; Chen CL; Li WY; Chen CJ
Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
[TBL] [Abstract][Full Text] [Related]
19. Molecular diagnosis of nasopharyngeal carcinoma using detection of Epstein-Barr virus latent membrane protein-1 gene in cervical metastatic lymph nodes.
Khademi B; Mahmoudi J; Monabati A; Maghsoudi B; Ashraf MJ; Mohammadianpanah M; Tabibi N; Valibeigi B; Abedi E
Am J Otolaryngol; 2009; 30(2):95-100. PubMed ID: 19239950
[TBL] [Abstract][Full Text] [Related]
20. The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma.
Guang-Wu H; Sunagawa M; Jie-En L; Shimada S; Gang Z; Tokeshi Y; Kosugi T
Laryngoscope; 2000 Dec; 110(12):2066-9. PubMed ID: 11129022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
